← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 10, 2018Last known activity
Jan 1, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (8 distinct, 4 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (4)
- NCT06186037Overall official - principal investigatorPhase 4Jan 1, 2024
- NCT05770674CollaboratorN/AApr 1, 2022
- NCT04970446Overall official - principal investigatorPhase 2/Phase 3Aug 1, 2021
- NCT03671590Study chairPhase 1Sep 10, 2018
Details
- Last known activity
- Jan 1, 2024